We are live on ! Find out more
OPCH icon

Option Care Health

341 hedge funds and large institutions have $5.65B invested in Option Care Health in 2024 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 147 increasing their positions, 115 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more repeat investments, than reductions

Existing positions increased: 147 | Existing positions reduced: 115

24% more call options, than puts

Call options by funds: $15.3M | Put options by funds: $12.4M

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0.62% less ownership

Funds ownership: 97.65%97.03% (-0.62%)

3% less capital invested

Capital invested by funds: $5.83B → $5.65B (-$181M)

3% less funds holding

Funds holding: 351341 (-10)

14% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 42

Holders
341
Holders Change
-10
Holders Change %
-2.85%
% of All Funds
4.91%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
36
Increased
147
Reduced
115
Closed
42
Calls
$15.3M
Puts
$12.4M
Net Calls
+$2.92M
Net Calls Change
-$5.29M
Name Holding Trade Value Shares
Change
Change in
Stake
TI
226
Tidal Investments
Wisconsin
$451K +$186K +5,733 +74%
VI
227
Vestcor Inc
New Brunswick, Canada
$450K
NIM
228
NEOS Investment Management
Connecticut
$437K +$174K +5,380 +70%
Nisa Investment Advisors
229
Nisa Investment Advisors
Missouri
$432K +$4.08K +126 +1%
SOW
230
State of Wyoming
Wyoming
$395K +$192K +5,927 +101%
RFC
231
Regions Financial Corp
Alabama
$394K +$3.24K +100 +0.9%
SPA
232
Sherbrooke Park Advisers
New York
$384K +$371K +11,451 New
Cambridge Investment Research Advisors
233
Cambridge Investment Research Advisors
Iowa
$378K +$4.4K +136 +1%
D.E. Shaw & Co
234
D.E. Shaw & Co
New York
$375K -$22.5M -696,271 -98%
PCM
235
Perkins Capital Management
Minnesota
$369K
CW
236
CreativeOne Wealth
Kansas
$365K +$70.3K +2,173 +25%
JIR
237
James Investment Research
Ohio
$355K +$194 +6 +0.1%
MYIA
238
Mount Yale Investment Advisors
Colorado
$343K -$1.13K -35 -0.3%
VPIM
239
Vanguard Personalized Indexing Management
California
$343K +$133K +4,118 +68%
Vontobel Holding
240
Vontobel Holding
Switzerland
$343K +$647 +20 +0.2%
GCM
241
Graham Capital Management
Connecticut
$341K -$1.07M -32,919 -76%
PA
242
Profund Advisors
Maryland
$329K +$12.1K +374 +4%
RJFSA
243
Raymond James Financial Services Advisors
Florida
$326K +$314K +9,715 New
Cetera Investment Advisers
244
Cetera Investment Advisers
Illinois
$314K +$303K +9,366 New
LA
245
Lindenwold Advisors
Pennsylvania
$312K +$6.99K +216 +2%
Los Angeles Capital Management
246
Los Angeles Capital Management
California
$307K
DAS
247
Diversify Advisory Services
Utah
$307K +$303K +9,349 New
CA
248
Clearstead Advisors
Ohio
$305K +$17.6K +545 +6%
MLICM
249
Metropolitan Life Insurance Company (MetLife)
New York
$295K -$23.2K -718 -8%
HIMC
250
Heritage Investors Management Corp
Maryland
$291K

OPCH Hedge Fund Activity: Q1 2024 in Review

341 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Option Care Health (OPCH) for Q1 2024, worth a combined $5.65B — down 3.1% from $5.83B a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of OPCH and 36 opened new positions — a net loss of 6 holders — while 115 trimmed existing stakes and 147 added.

The largest buyer was Thrivent Financial for Lutherans, adding an estimated $79.4M. The largest seller was Morgan Stanley, cutting an estimated $96.6M.

  • 341 institutional investors held Option Care Health (OPCH) as of Q1 2024, down from 351 in Q4 2023.
  • Funds reported $5.65B of Option Care Health stock for Q1 2024, down 3.1% quarter-over-quarter.
  • 36 funds opened new Option Care Health positions in Q1 2024 and 42 closed out, a net change of -6 holders.
  • The largest Option Care Health buyer in Q1 2024 was Thrivent Financial for Lutherans, an estimated $79.4M added.
  • The largest Option Care Health seller in Q1 2024 was Morgan Stanley, an estimated $96.6M sold.

Based on aggregated 13F filings for Q1 2024.